Shandong Pharmaceutical Glass Co has announced its 2009 annual report, realising operating revenue of CNY 1.242BN for the period, an increase of 7.24%, compared to the same period 2008. Total profit was CNY 173M, up 8.74%, with net profit of CNY 144M belonging to the stockholders, an increase of 6.81%. Shandong is the largest pharmaceutical glass company in China. In its 2009 annual report, exports decrease slightly, while domestic demand was stable, despite the adverse global economic situation.
Origin
Unknown
Journal Title
Gmpa 3/2010 21
Sector
News Items
Class
N 2464